---
title: "Calendula officinalis — Evidence-Based Clinical Monograph"
category: "Herbal Medicine"
tags:
  [
    "calendula",
    "wound healing",
    "anti-inflammatory",
    "radiation dermatitis",
    "antimicrobial",
    "topical application",
    "burn treatment",
    "venous ulcers",
    "mucositis",
    "evidence-based",
  ]
date: "2025-01-15"
source: "Comprehensive Clinical Research Compilation"
botanical_name: "Calendula officinalis"
common_names: ["Calendula", "Pot Marigold", "Garden Marigold"]
family: "Asteraceae (Compositae)"
primary_actions:
  ["Anti-inflammatory", "Wound healing", "Antimicrobial", "Antioxidant"]
evidence_grade: "B (Strong for wound healing, moderate for other indications)"
safety_class: "Generally safe; caution in Compositae allergy"
---

# Calendula officinalis — Evidence-Based Clinical Monograph

**Context:** Calendula officinalis (pot marigold) is a flowering plant in the Asteraceae family with extensive historical and modern clinical use for wound healing, skin inflammation, and radiation dermatitis. Native to the Mediterranean region, it has been validated through multiple randomized controlled trials for topical applications. This monograph synthesizes phytochemistry, clinical evidence, comparative effectiveness, safety data, and practical clinical protocols.

## Key Therapeutic Highlights

**Primary Evidence-Based Uses:**

- **Wound Healing (Grade B):** Accelerates healing of venous leg ulcers (72% vs 32% healing rate), acute hand/finger wounds (8.6 vs 13.2 days to epithelialization), and burn wounds
- **Oral Health (Grade B):** Reduces dental plaque and gingivitis; superior taste acceptability vs chlorhexidine
- **Pediatric Dermatology (Grade B):** Safe and effective for diaper dermatitis in infants
- **Gynecological Care (Grade B):** Effective for post-episiotomy healing and vaginal infections
- **Radiation Support (Grade C):** Conflicting evidence for radiation dermatitis prevention; best for symptomatic relief

**Key Phytochemicals:**

- Triterpenoid esters (faradiol derivatives): Principal anti-inflammatory agents, comparable to indomethacin
- Flavonoids (quercetin, rutin, hyperoside): Antioxidant and anti-inflammatory via NF-κB inhibition
- Carotenoids (lutein, zeaxanthin): Antioxidant and tissue repair support
- Phenolic acids: Radical scavenging and metal chelation
- Essential oils and saponins: Antimicrobial properties

**Safety Profile:**

- Generally safe for topical use (LD50 >4640 mg/kg oral in mice)
- Main risk: Allergic contact dermatitis (~0.2-1.0% incidence)
- Contraindicated in Compositae family allergy
- Not recommended during pregnancy/lactation due to insufficient data

**Clinical Pearl:** Standardization matters—extracts with 6-7% faradiol esters and ≥0.4% flavonoids (as hyperoside) show optimal anti-inflammatory activity. Hydroglycolic extracts (e.g., Plenusdermax®) demonstrate superior clinical outcomes for chronic wounds.

**Cross-References to Related Documents:**
- **Inflammation-Immune-Anatomy-Mechanisms.md** - For NF-κB pathway, COX-2 inhibition, and inflammatory mediator mechanisms
- **Immune-Respiratory-Clinical-Guide.md** - For wound healing protocols and topical application guidance
- **Digestive-System-Anatomy-Mechanisms.md** - For mucositis management and oral health applications
- **Cardiovascular-Anatomy-Mechanisms.md** - For understanding angiogenesis mechanisms (VEGF, TGF-β)
- **Cellular-Biochemistry-Herbal-Actions.md** - For antioxidant mechanisms and cellular protection pathways

**Related Herbal Monographs:**
- **Aloe Vera** - Complementary wound healing with different mechanisms
- **Chamomile** - Related Asteraceae family herb for topical inflammation
- **Echinacea** - Immune support and wound healing applications

## Pharmacology & Phytochemistry

_Calendula officinalis_, commonly known as marigold, holds significant historical and modern therapeutic importance due to its rich and diverse phytochemical composition [[2](https://www.sciencedirect.com/science/article/abs/pii/S2950199724001289), [4](https://journals.sagepub.com/doi/10.1177/1934578X241259021)]. Its biological activities are attributed to a complex mixture of secondary metabolites, primarily concentrated in the flower heads, which include flavonoids, triterpenoids, carotenoids, phenolic acids, saponins, and volatile oils [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [14](https://www.mdpi.com/1424-8247/16/4/611)]. The intricate interplay of these compounds underpins its well-documented anti-inflammatory, antioxidant, antimicrobial, and wound-healing properties [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)]. A thorough understanding of this chemical foundation is essential for interpreting its clinical applications and mechanistic actions.

The most extensively studied classes of compounds in _Calendula officinalis_ are flavonoids and triterpenoid derivatives. Flavonoids such as quercetin, isorhamnetin, isoquercetin, rutin, and hyperoside are consistently identified as key contributors to its therapeutic effects [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [4](https://journals.sagepub.com/doi/10.1177/1934578X241259021), [15](https://www.pnrjournal.com/index.php/home/article/download/8726/11904/10489)]. These polyphenolic compounds are renowned for their potent antioxidant and anti-inflammatory activities [[4](https://journals.sagepub.com/doi/10.1177/1934578X241259021), [14](https://www.mdpi.com/1424-8247/16/4/611)]. Their mechanism of action involves scavenging free radicals like superoxide and hydroxyl radicals, chelating metal ions, and inhibiting pro-inflammatory signaling pathways [[4](https://journals.sagepub.com/doi/10.1177/1934578X241259021), [9](https://www.mdpi.com/2079-9284/8/2/31)]. Specifically, flavonoids like quercetin and related polyphenolics may inhibit the activation of transcription factors such as NF-kappaB and STAT-1, which regulate the expression of inflammatory cytokines and inducible nitric oxide synthase (iNOS) [[9](https://www.mdpi.com/2079-9284/8/2/31)]. Another critical group of phytochemicals responsible for Calendula's effects are the pentacyclic triterpenoid fatty acid esters, particularly faradiol monoesters like faradiol 3-O-laurate, faradiol 3-O-palmitate, and faradiol 3-O-myristate [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf), [33](https://pmc.ncbi.nlm.nih.gov/articles/PMC3834722/)]. These lipophilic compounds are considered the principal agents for its topical anti-inflammatory activity, with some studies showing unesterified faradiol to have effects comparable to an equimolar dose of the NSAID indomethacin [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf), [33](https://pmc.ncbi.nlm.nih.gov/articles/PMC3834722/)]. The European Pharmacopoeia specifically recommends using the ligulate ray florets of the flower, which contain higher concentrations of these active esters compared to other plant parts [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)].

Carotenoids, including lutein, zeaxanthin, and β-carotene, are another major constituent class, predominantly found in the petals of the flower [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [4](https://journals.sagepub.com/doi/10.1177/1934578X241259021)]. These pigments contribute significantly to the plant's antioxidant capacity and play a role in skin health and healing [[27](https://pmc.ncbi.nlm.nih.gov/articles/PMC9827526/)]. As precursors to vitamin A, they support epithelial tissue integrity and repair [[27](https://pmc.ncbi.nlm.nih.gov/articles/PMC9827526/)]. Phenolic acids, such as chlorogenic acid, caffeic acid, and ferulic acid, further bolster the extract's antioxidant profile by contributing to radical scavenging and metal chelation [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [7](https://www.nature.com/articles/s41598-025-16937-y), [12](https://www.sciencedirect.com/science/article/abs/pii/S0003267013011458)]. Essential oils, containing compounds like limonene, α-pinene, and nerolidol, also contribute to the plant's biological activity, with essential oil extracts demonstrating antimicrobial effects against various bacteria and fungi [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [13](https://www.ukaazpublications.com/publications/?sdm_process_download=1&download_id=11898)]. Saponins, polysaccharides, coumarins (scopoletin, umbelliferone), and sterols are additional components that contribute to the plant's multifaceted pharmacological profile, including immunomodulatory and spasmolytic effects [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [13](https://www.ukaazpublications.com/publications/?sdm_process_download=1&download_id=11898), [16](https://ijtinnovation.com/admin/assets/article_issue/1726465209JMPAS_JULY-AUGUST-2024.pdf)].

The broad spectrum of pharmacological activities observed with _Calendula officinalis_ can be directly linked to these phytochemical constituents and their synergistic interactions. Its anti-inflammatory action is one of the most robustly supported mechanisms, involving multiple points of intervention. Calendula extracts effectively suppress the production of key pro-inflammatory mediators, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and interferon-gamma (IFN-γ) [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [9](https://www.mdpi.com/2079-9284/8/2/31)]. This is achieved through the inhibition of cyclooxygenase-2 (COX-2) enzyme activity, thereby reducing prostaglandin synthesis, and the suppression of inducible nitric oxide synthase (iNOS), leading to decreased nitric oxide (NO) production [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [9](https://www.mdpi.com/2079-9284/8/2/31), [14](https://www.mdpi.com/1424-8247/16/4/611)]. Triterpenoid esters are primarily implicated in these effects, while flavonoids may modulate upstream signaling pathways like NF-κB [[9](https://www.mdpi.com/2079-9284/8/2/31), [14](https://www.mdpi.com/1424-8247/16/4/611)]. This multi-pronged anti-inflammatory approach is central to its utility in treating skin inflammations, wounds, and radiodermatitis.

Antioxidant activity is another cornerstone of Calendula's therapeutic profile. The high concentration of flavonoids and phenolic acids allows the extracts to neutralize reactive oxygen species (ROS) and reactive nitrogen species (RNS) through direct electron transfer [[4](https://journals.sagepub.com/doi/10.1177/1934578X241259021), [9](https://www.mdpi.com/2079-9284/8/2/31)]. In vitro assays consistently demonstrate strong radical scavenging capacity against DPPH, ABTS, and superoxide radicals, with IC50 values as low as 6.5 µg/mL for ABTS radicals [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [4](https://journals.sagepub.com/doi/10.1177/1934578X241259021)]. Beyond direct scavenging, Calendula enhances the body's endogenous antioxidant defenses by increasing the levels and activity of enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GST) [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00440/full)]. This dual-action mechanism—quenching external free radicals and boosting internal enzymatic systems—protects cells from oxidative stress, a key driver of inflammation and tissue damage during wound healing and disease processes [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00440/full)].

The promotion of wound healing is perhaps the most clinically relevant pharmacological effect of _Calendula officinalis_. Its mechanism is highly complex and involves orchestrating multiple phases of the healing cascade. Preclinical studies show that Calendula treatment accelerates wound contraction and increases tensile strength in animal models, indicating enhanced collagen synthesis and maturation [[3](https://www.ijbcp.com/index.php/ijbcp/article/view/3388), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)]. It stimulates the proliferation of fibroblasts and keratinocytes, the primary cells responsible for producing new connective tissue and epithelializing the wound surface [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. Furthermore, Calendula modulates the expression of crucial growth factors, including vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), and epidermal growth factor (EGF), which are vital for angiogenesis (new blood vessel formation) and tissue regeneration [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. By downregulating pro-inflammatory cytokines and myeloperoxidase (MPO), it helps resolve the initial inflammatory phase more efficiently, creating a favorable microenvironment for repair [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. The presence of saponins and flavonoids has been shown to stimulate angiogenesis, further supporting tissue regeneration [[13](https://www.ukaazpublications.com/publications/?sdm_process_download=1&download_id=11898)].

Finally, _Calendula officinalis_ exhibits notable antimicrobial activity against a range of pathogens, making it useful for preventing infection in open wounds. Extracts have demonstrated effectiveness against Gram-positive bacteria like _Staphylococcus aureus_ and _Bacillus subtilis_, as well as Gram-negative bacteria such as _Pseudomonas aeruginosa_ and _Escherichia coli_ [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [4](https://journals.sagepub.com/doi/10.1177/1934578X241259021), [13](https://www.ukaazpublications.com/publications/?sdm_process_download=1&download_id=11898)]. The minimum inhibitory concentration (MIC) for aqueous extract against several key pathogens was found to be 3.75%, with a minimum bactericidal concentration (MBC) of 1.87% [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [14](https://www.mdpi.com/1424-8247/16/4/611)]. Antifungal activity against _Candida albicans_ has also been reported, although it is generally weaker than that of standard antifungals like chlorhexidine [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [13](https://www.ukaazpublications.com/publications/?sdm_process_download=1&download_id=11898)]. The mechanism of action is thought to involve the disruption of microbial cell membranes by saponins and terpenoids, potentially leading to leakage of cellular contents and death [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [82](https://journals.lww.com/ijob/fulltext/2018/26010/nanocrystalline_silver_gel_versus_conventional.8.aspx)]. While its antimicrobial potency may not match that of potent antibiotics, its anti-inflammatory and wound-healing properties make it a valuable adjunctive therapy in wound management.

**Section Summary — Pharmacology & Phytochemistry:** Calendula's therapeutic effects stem from synergistic interactions among flavonoids (antioxidant, anti-inflammatory via NF-κB inhibition), triterpenoid esters (potent anti-inflammatory comparable to NSAIDs), carotenoids (tissue repair), and phenolic acids (radical scavenging). The plant demonstrates multi-mechanistic action including COX-2 and iNOS inhibition, enhancement of endogenous antioxidant enzymes (SOD, CAT, GPx), stimulation of growth factors (VEGF, TGF-β, EGF), and antimicrobial membrane disruption. Standardization to ≥6% faradiol esters and ≥0.4% flavonoids ensures optimal clinical activity.

## Human Clinical Evidence Map

The clinical application of _Calendula officinalis_ is supported by a growing body of evidence, though the quality and consistency of this evidence vary significantly across different indications. A systematic evaluation reveals a clear hierarchy of evidence, with the strongest support for its use in wound healing, followed by moderate evidence for oral health and gynecological applications, and highly contentious evidence for radiation dermatitis. This section provides a structured map of the available human clinical data, grading the strength of evidence for each key indication based on the study designs cited in the provided sources.

| Indication                                     | Grade | Best Study Type             |       n       | Dose/Form                                   | Duration      | Primary Outcome                       | Effect Size (CI/p)                                                                  | Key PMIDs                                                                                                                                                                                                                                                  | Bottom Line                                                                                                                                                                      |
| :--------------------------------------------- | :---- | :-------------------------- | :-----------: | :------------------------------------------ | :------------ | :------------------------------------ | :---------------------------------------------------------------------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Venous Leg Ulcer Healing**                   | B     | Prospective Pilot Study     |      57       | Plenusdermax® spray (hydroglycolic extract) | 30 weeks      | Complete epithelialization rate       | 72% vs 32% (p < 0.05)                                                               | [[57](https://practicalimplementationofnursingscience.org/articles/10.29024/pins.31), [64](https://www.researchgate.net/publication/311691265_Therapeutic_effectiveness_of_a_Calendula_officinalis_extract_in_venous_leg_ulcer_healing)]                   | Calendula hydroglycolic extract demonstrates significant efficacy in promoting venous leg ulcer healing, increasing weekly healing velocity four-fold compared to standard care. |
| **Acute Wound Healing**                        | B     | Randomized Controlled Trial |      20       | Standardized extract cream                  | Not specified | Epithelization time / Healing speed   | 8.6 vs 13.2 days; 9.5 vs 6.2%/day (p < 0.05)                                        | [[67](https://www.researchgate.net/publication/370100513_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial_View_supplementary_material_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial)] | Topical standardized extract of _Calendula officinalis_ significantly accelerates the healing of acute hand and finger wounds compared to mineral oil.                           |
| **Radiation Dermatitis Prevention**            | C     | Randomized Controlled Trial |      254      | Calendula cream                             | Not specified | Incidence of grade ≥2 dermatitis      | 41% vs 63% vs Trolamine (p < 0.001)                                                 | [[39](https://www.scielo.br/j/reben/a/JFZQfd53VjNDhsphxLxxJ7D/?lang=en), [72](https://pubmed.ncbi.nlm.nih.gov/15084618/)]                                                                                                                                  | Early evidence suggests Calendula is superior to trolamine for preventing severe radiation dermatitis, but subsequent high-quality trials have failed to replicate this finding. |
| **Radiation Dermatitis Prevention**            | D     | Randomized Controlled Trial |      81       | Calendula lotion vs Sorbolene cream         | Not specified | Prevalence of grade 2+ dermatitis     | No statistically significant difference (OR = 0.87, 95% CI: [0.36, 2.09], P = 0.92) | [[42](https://www.researchgate.net/publication/344358512_Efficacy_of_topical_Calendula_officinalis_on_prevalence_of_radiation-induced_dermatitis_A_randomised_controlled_trial)]                                                                           | Recent large-scale RCTs comparing Calendula to standard moisturizers found no significant benefit, contributing to guidelines advising against its routine use.                  |
| **Burn Wound Healing**                         | B     | Triple-Blind Clinical Trial |      60       | Oral capsules (2 g/day)                     | 14 days       | Wound status improvement (BWAT score) | Significant improvement in intervention group (P < 0.001)                           | [[27](https://pmc.ncbi.nlm.nih.gov/articles/PMC9827526/), [61](https://www.researchgate.net/figure/Comparison-of-wound-healing-index-in-the-two-groups_tbl3_366880930)]                                                                                    | Oral administration of _Calendula officinalis_ extract significantly improves the healing of second-degree burn wounds compared to controls.                                     |
| **Post-Episiotomy Wound Healing**              | B     | Parallel-group RCT          |      100      | Calendula ointment                          | Not specified | Postpartum recovery                   | Reduced discomfort, bleeding, dyspareunia                                           | [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [14](https://www.mdpi.com/1424-8247/16/4/611)]                                                                                                                                  | Topical Calendula ointment is effective in improving the healing process and reducing discomfort after episiotomy.                                                               |
| **Oral Health (Plaque/Gingivitis)**            | B     | Double-Blind Study          |      240      | Calendula mouthwash                         | 6 months      | Plaque and gingivitis scores          | Outperformed placebo; reduced plaque and gingivitis scores over six months          | [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]                                                                                                                                                                                 | Calendula mouthwash is an effective agent for reducing dental plaque and gingivitis, with some studies suggesting better taste than chlorhexidine.                               |
| **Oropharyngeal Mucositis**                    | B     | Clinical Trial              | Not specified | Calendula extract mouthwash                 | Not specified | Reduction of mucositis severity       | Improved compared to placebo                                                        | [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [14](https://www.mdpi.com/1424-8247/16/4/611)]                                                                                                                                  | Topical calendula extract mouthwash can alleviate radiation-induced oropharyngeal mucositis in head-and-neck cancer patients.                                                    |
| **Diabetic Foot Ulcer Healing**                | C     | Prospective Pilot Study     |      41       | Plenusdermax® spray (hydroglycolic extract) | 30 weeks      | Complete wound closure                | 78% complete closure within 30 weeks                                                | [[53](https://pmc.ncbi.nlm.nih.gov/articles/PMC10046143/)]                                                                                                                                                                                                 | Preliminary evidence suggests a hydroglycolic extract of _Calendula_ may accelerate healing in diabetic foot ulcers, but larger RCTs are needed to confirm these findings.       |
| **Diaper Dermatitis**                          | B     | Randomized Controlled Trial | Not specified | Calendula ointment (topical)                | Not specified | Dermatitis severity improvement       | Significant improvement vs control                                                  | [[90](https://pubmed.ncbi.nlm.nih.gov/22789794/), [91](https://doi.org/10.1016/j.ctcp.2012.02.003)]                                                                                                                                                        | Topical calendula ointment (Panahi et al., 2012) is safe and effective for treating diaper dermatitis in infants, providing a natural therapeutic alternative.                   |
| **Dental Plaque & Gingivitis (Khairnar 2013)** | B     | Clinical Trial              |      240      | Calendula mouthwash                         | 6 months      | Plaque and Gingival Index             | Significant reduction; better taste acceptability vs chlorhexidine                  | [[92](https://pubmed.ncbi.nlm.nih.gov/23633851/)]                                                                                                                                                                                                          | Calendula mouthwash effectively reduces dental plaque and gingivitis with superior patient acceptability compared to chlorhexidine.                                              |
| **Vaginal Infections**                         | B     | Clinical Trial              | Not specified | Calendula cream/lotion                      | Not specified | Resolution of infection symptoms      | Effective without adverse effects                                                   | [[93](https://doi.org/10.22038/ijogi.2017.10060)]                                                                                                                                                                                                          | Calendula cream (Saffari et al., 2017) shows efficacy for vaginal candidiasis and bacterial vaginosis with good tolerability.                                                    |

For the indication of **venous leg ulcers**, the evidence is graded as 'B' due to a compelling prospective pilot study. This trial, conducted over 30 weeks, utilized Plenusdermax®, a hydroglycolic extract of _Calendula officinalis_, applied as a spray twice daily [[64](https://www.researchgate.net/publication/311691265_Therapeutic_effectiveness_of_a_Calendula_officinalis_extract_in_venous_leg_ulcer_healing), [66](https://pdfs.semanticscholar.org/e077/5ba226584c250447cb29f2a78e793ce62abf.pdf)]. The results were striking: the treatment group achieved a 72% rate of complete epithelialization, compared to only 32% in the control group receiving standard care (collagenase, chloramphenicol, and silver sulfadiazine) [[57](https://practicalimplementationofnursingscience.org/articles/10.29024/pins.31), [64](https://www.researchgate.net/publication/311691265_Therapeutic_effectiveness_of_a_Calendula_officinalis_extract_in_venous_leg_ulcer_healing)]. The average healing time was approximately 12 weeks in the Calendula group versus 25 weeks in controls, representing a four-fold increase in the percentage of healing velocity per week (7.4% vs 1.7%) [[57](https://practicalimplementationofnursingscience.org/articles/10.29024/pins.31), [64](https://www.researchgate.net/publication/311691265_Therapeutic_effectiveness_of_a_Calendula_officinalis_extract_in_venous_leg_ulcer_healing)]. These findings suggest a substantial clinical benefit and highlight the potential of standardized Calendula extracts for chronic wound management.

In the context of **acute wound healing**, particularly for injuries sustained by the hands and fingers, a randomized controlled trial (RCT) provided high-quality evidence ('B'). The study compared a standardized extract of _Calendula officinalis_ (SEC) to mineral oil as a control for wounds healing by secondary intention [[67](https://www.researchgate.net/publication/370100513_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial_View_supplementary_material_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial)]. The SEC group exhibited significantly faster healing, with an epithelialization time of 8.6 days compared to 13.2 days in the control group (p < 0.05) and a healing speed of 9.5% per day versus 6.2% per day in controls (p < 0.05) [[67](https://www.researchgate.net/publication/370100513_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial_View_supplementary_material_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial)]. This demonstrates that a well-defined formulation can reliably accelerate the closure of acute traumatic wounds.

The evidence for **radiation dermatitis prevention** is the most complex and controversial. Initially, a landmark Phase III RCT by Pommier et al. (n=254) showed strong positive results ('B') [[72](https://pubmed.ncbi.nlm.nih.gov/15084618/)]. Twice-daily application of Calendula cream significantly reduced the incidence of grade ≥2 acute dermatitis compared to trolamine (41% vs 63%, p < 0.001) [[39](https://www.scielo.br/j/reben/a/JFZQfd53VjNDhsphxLxxJ7D/?lang=en), [72](https://pubmed.ncbi.nlm.nih.gov/15084618/)]. However, this promising result has not been consistently replicated in subsequent, often larger, RCTs. A double-blind RCT by Sharp et al. (n=411) found no significant difference between Calendula cream and aqueous cream [[41](https://pmc.ncbi.nlm.nih.gov/articles/PMC4665477/)]. Similarly, a later RCT by Siddiquee et al. (n=81) found no benefit compared to the standard-of-care Sorbolene cream [[42](https://www.researchgate.net/publication/344358512_Efficacy_of_topical_Calendula_officinalis_on_prevalence_of_radiation-induced_dermatitis_A_randomised_controlled_trial)]. Due to this inconsistency, the overall evidence grade is now 'C', and recent systematic reviews and guidelines, such as those from MASCC, do not recommend its routine use, citing insufficient evidence [[22](https://www.cda-amc.ca/sites/default/files/pdf/htis/2017/RC0853%20Topical%20Antibiotics%20for%20Infected%20Wounds%20Final.pdf), [41](https://pmc.ncbi.nlm.nih.gov/articles/PMC4665477/), [74](<https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00063-9/fulltext>)].

Regarding **burn wound healing**, evidence is also graded 'B'. A triple-blind clinical trial evaluated oral administration of _Calendula officinalis_ capsules (2 grams per day) for 14 days in patients with second-degree burns [[27](https://pmc.ncbi.nlm.nih.gov/articles/PMC9827526/)]. Using the Bates-Jensen Wound Assessment Tool (BWAT), the intervention group showed a significant reduction in wound scores compared to controls, with the difference being statistically significant on both day 7 and day 14 (P < 0.001) [[27](https://pmc.ncbi.nlm.nih.gov/articles/PMC9827526/)]. This indicates that oral supplementation can positively impact the healing trajectory of burn wounds.

For **post-episiotomy care**, an RCT (n=100) provides strong evidence ('B'). The study found that applying a Calendula ointment topically significantly improved the healing of cesarean wounds, reducing postpartum discomfort, bleeding, and dyspareunia compared to standard care [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [14](https://www.mdpi.com/1424-8247/16/4/611)]. This highlights its value in obstetric and gynecological supportive care.

Evidence for **oral health** is also graded 'B'. Multiple studies support the use of Calendula mouthwash for reducing dental plaque and gingivitis [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. One double-blind study noted that Calendula mouth rinse outperformed chlorhexidine in plaque control and had a better taste [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. Furthermore, a clinical trial confirmed that a calendula extract mouthwash effectively reduces radiation-induced oropharyngeal mucositis in head-and-neck cancer patients, providing a valuable supportive therapy [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [14](https://www.mdpi.com/1424-8247/16/4/611)].

Finally, for **diabetic foot ulcers (DFUs)**, the evidence is preliminary ('C'). A prospective pilot study using a hydroglycolic extract (Plenusdermax®) reported a 78% complete wound closure rate within 30 weeks, along with significant reductions in bacterial colonization and patient-reported pain [[53](https://pmc.ncbi.nlm.nih.gov/articles/PMC10046143/)]. However, a separate systematic review identified at least one RCT where Calendula showed no improvement in diabetic leg ulcer healing [[6](https://pubmed.ncbi.nlm.nih.gov/31145533/), [29](https://onlinelibrary.wiley.com/doi/abs/10.1111/wrr.12737)]. This conflict underscores the need for larger, well-designed RCTs to clarify its role in this challenging clinical area.

**Diaper dermatitis** represents another validated indication for topical Calendula use. Panahi et al. (2012) conducted an RCT demonstrating that calendula ointment significantly improved diaper dermatitis severity compared to control treatments [[90](https://pubmed.ncbi.nlm.nih.gov/22789794/), [91](https://doi.org/10.1016/j.ctcp.2012.02.003)]. This finding is particularly relevant for pediatric care, as it offers a safe, natural alternative to conventional treatments with minimal risk of adverse effects in the sensitive infant population. The evidence grade is 'B', reflecting the strength of the controlled trial design.

For **dental health applications**, Khairnar et al. (2013) provided compelling evidence in a study of 240 participants using calendula mouthwash over six months [[92](https://pubmed.ncbi.nlm.nih.gov/23633851/)]. The trial showed significant reductions in both Plaque Index and Gingival Index scores, with the added benefit of superior taste acceptability compared to chlorhexidine, the standard antimicrobial mouthwash. This advantage in patient acceptability could translate to better adherence in clinical practice, making Calendula an attractive option for managing chronic gingivitis and plaque accumulation.

Additionally, Saffari et al. (2017) investigated the use of **Calendula cream for vaginal infections**, including candidiasis and bacterial vaginosis [[93](https://doi.org/10.22038/ijogi.2017.10060)]. The study found that Calendula was effective in resolving infection symptoms without adverse effects, demonstrating its antimicrobial properties in a gynecological context. This application expands Calendula's therapeutic repertoire beyond dermatological and wound-healing indications.

**Section Summary — Clinical Evidence:** The strongest evidence (Grade B) supports Calendula for venous leg ulcers (72% vs 32% healing), acute wound healing (accelerated by ~4.6 days), burn wounds (oral dosing at 2g/day), post-episiotomy care, diaper dermatitis, dental plaque/gingivitis, and gynecological infections. Radiation dermatitis prevention evidence is conflicting (Grade C-D), with initial positive results not consistently replicated—topical corticosteroids remain superior. Key clinical trials include Pommier 2004 (radiation), Giostri 2022 (acute wounds), Buzzi 2016 (venous ulcers), Panahi 2012 (diaper dermatitis), and Khairnar 2013 (dental). Hydroglycolic extracts (Plenusdermax®) show particularly strong performance in chronic wound management.

## Dosing, Formulations & Standardization

The therapeutic efficacy of _Calendula officinalis_ is profoundly influenced by its preparation, including the choice of solvent for extraction, the final formulation, and the degree of phytochemical standardization. Clinicians must understand these variables to select appropriate products and interpret clinical trial data accurately. The provided sources detail a wide array of preparations, from traditional tinctures and ointments to advanced nanoemulsions and hydrogels, highlighting the evolution of Calendula-based medicines.

Formulation plays a critical role in determining the bioavailability and activity of Calendula's bioactive compounds. The choice of extraction solvent is paramount because different phytochemicals have varying solubilities. Lipophilic triterpenoid esters, which are primarily responsible for the anti-inflammatory effects, are best extracted using less polar solvents like dichloromethane or ethyl acetate [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]. In contrast, polar solvents like water or ethanol/water mixtures are more effective for extracting flavonoids and other phenolic compounds [[11](https://pmc.ncbi.nlm.nih.gov/articles/PMC3379952/), [17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]. One study demonstrated that dichloromethane consistently yielded greater amounts of active ingredients, such as chlorogenic acid, compared to ethanol from commercial formulations, reinforcing the advantage of non-polar solvents for certain phytoconstituents [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]. Consequently, a lipophilic ethyl acetate-soluble fraction of a methanol extract showed 84% w/v inhibition of induced inflammation, whereas an aqueous-ethanol extract showed only 20% w/v inhibition, underscoring the significant impact of extraction method on anti-inflammatory potency [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)].

The table below summarizes various dosing forms and preparations used in clinical and preclinical studies, illustrating the diversity of available products.

| Form                          | Adult Dose (per dose)  | Daily Range   | Frequency           | Timing                  | Standardization (% marker)                                                  | Equivalency                                        | Clinical Context                                      | Sources (PMIDs)                                                                                                                                                                                                                                                                                                                                                                     |
| :---------------------------- | :--------------------- | :------------ | :------------------ | :---------------------- | :-------------------------------------------------------------------------- | :------------------------------------------------- | :---------------------------------------------------- | :---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Topical Cream/Ointment**    | Not specified          | Not specified | Several times daily | Not specified           | 1% freeze-dried extract standardized to 1.2% total flavonoids as hyperoside | Roseneath Organics Calendula lotion (≤5% v/v)      | Venous leg ulcers, Acute wounds, Radiation dermatitis | [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf), [42](https://www.researchgate.net/publication/344358512_Efficacy_of_topical_Calendula_officinalis_on_prevalence_of_radiation-induced_dermatitis_A_randomised_controlled_trial)] |
| **Topical Cream/Ointment**    | Not specified          | Not specified | Twice daily         | Throughout radiotherapy | Standardized to 6.0–7.0% faradiol esters, 0.25% carotenoids                 | Boiron Ltd. _Pommade au Calendula par Digestion_   | Radiation dermatitis                                  | [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf), [72](https://pubmed.ncbi.nlm.nih.gov/15084618/)]                                                                                                                                |
| **Topical Cream/Ointment**    | Not specified          | Not specified | Not specified       | Throughout radiotherapy | Homeopathic 10%                                                             | Italy (homeopathic)                                | Radiation dermatitis                                  | [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]                                                                                                                                                                                 |
| **Topical Gel**               | 5%, 7%, or 10% (w/v)   | 7% (optimal)  | Not specified       | Not specified           | Butanolic extract                                                           | Rat wound healing model                            | General wound healing                                 | [[30](https://biomedpharmajournal.org/vol8no2/comparison-of-different-concentrations-of-calendula-officinalis-gel-on-cutaneous-wound-healing/)]                                                                                                                                                                                                                                     |
| **Topical Lotion**            | Not specified          | Not specified | Not specified       | Not specified           | ≤5% v/v (Roseneath Organics)                                                | Not specified                                      | Radiation dermatitis                                  | [[42](https://www.researchgate.net/publication/344358512_Efficacy_of_topical_Calendula_officinalis_on_prevalence_of_radiation-induced_dermatitis_A_randomised_controlled_trial)]                                                                                                                                                                                                    |
| **Topical Ointment**          | Not specified          | Not specified | Not specified       | Throughout radiotherapy | Not specified                                                               | Australia (equivalent to 71 mg dry flower per 1 g) | Radiation dermatitis                                  | [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]                                                                                                                                                                                 |
| **Topical Solution/Dressing** | 10% Calendula tincture | Not specified | Not specified       | Not specified           | Not specified                                                               | Not specified                                      | Chronic wounds (burns, ulcers)                        | [[28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)]                                                                                                                                                                                                                                                                                                           |
| **Topical Spray**             | Not specified          | Not specified | Twice daily         | For 30 weeks            | Hydroglycolic extract (Plenusdermax®)                                       | Not specified                                      | Venous leg ulcers, Diabetic foot ulcers               | [[64](https://www.researchgate.net/publication/311691265_Therapeutic_effectiveness_of_a_Calendula_officinalis_extract_in_venous_leg_ulcer_healing), [70](https://journals.sagepub.com/doi/pdf/10.1089/wound.2024.0129)]                                                                                                                                                             |
| **Oral Capsules**             | 2 g                    | 2 g/day       | Once daily          | For 14 days             | Not specified                                                               | Not specified                                      | Burn wound healing                                    | [[27](https://pmc.ncbi.nlm.nih.gov/articles/PMC9827526/), [61](https://www.researchgate.net/figure/Comparison-of-wound-healing-index-in-the-two-groups_tbl3_366880930)]                                                                                                                                                                                                             |
| **Oral Tincture**             | 1–2 tsp (5–10 mL)      | Not specified | Not specified       | Gargle/lotion           | Not specified                                                               | Not specified                                      | Oral/pharyngeal inflammation                          | [[89](https://www.ncbi.nlm.nih.gov/books/NBK92761/)]                                                                                                                                                                                                                                                                                                                                |
| **Water-in-Oil Nanoemulsion** | Not specified          | Not specified | Not specified       | Not specified           | Not specified                                                               | Not specified                                      | Anti-inflammatory delivery                            | [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/)]                                                                                                                                                                                                                                                                                                                           |
| **Hydrogel Sheet/Film**       | Not specified          | Not specified | Not specified       | Not specified           | Not specified                                                               | Not specified                                      | Bilayer wound dressing                                | [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [61](https://www.researchgate.net/figure/Comparison-of-wound-healing-index-in-the-two-groups_tbl3_366880930)]                                                                                                                                                                                            |

Standardization is a cornerstone of quality control and ensures batch-to-batch consistency and predictable efficacy. Several markers are used for this purpose. The sum of flavonoids expressed as hyperoside is a common standard, with both the State Pharmacopoeia of Ukraine and the European Pharmacopoeia requiring a minimum of 0.4% [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators), [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC3379952/)]. Other key flavonoid markers include isorhamnetin-3-O-rutinoside and rutin [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators), [12](https://www.sciencedirect.com/science/article/abs/pii/S0003267013011458)]. For anti-inflammatory activity, the quantification of faradiol esters is becoming increasingly important, with some commercial extracts standardized to contain 6.0–7.0% of these compounds [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]. Novel markers like syringic acid have also been proposed for quality control using validated HPLC and HPTLC methods [[18](https://rjptonline.org/AbstractView.aspx?PID=2023-16-4-65)]. Modern analytical techniques such as High-Performance Thin-Layer Chromatography (HPTLC) and High-Performance Liquid Chromatography (HPLC) are essential tools for fingerprinting and quantifying these marker compounds, ensuring product authenticity and potency [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators), [15](https://www.pnrjournal.com/index.php/home/article/download/8726/11904/10489)].

Delivery systems represent a frontier for enhancing Calendula's therapeutic potential. Innovations aim to improve stability, bioaccessibility, and targeted delivery of its bioactive compounds. Water-in-oil nanoemulsions have been developed to enhance the bioaccessibility and effectiveness of polyphenolic compounds, ultimately augmenting their health benefits [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/)]. Polyurethane-based bilayer wound dressings incorporating Calendula extract have demonstrated enhanced antibacterial properties and biocompatibility, making them suitable for chronic wound management [[61](https://www.researchgate.net/figure/Comparison-of-wound-healing-index-in-the-two-groups_tbl3_366880930)]. Electrospun nanofibers containing Calendula have achieved 87.5% wound closure in rat models by day 14, showcasing the potential of advanced materials for regenerative medicine [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. Chitosan-based hydrogels with Calendula extract have also been shown to improve wound healing outcomes [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. These advanced formulations move beyond simple ointments and creams, offering controlled release and sustained therapeutic action, which could lead to improved clinical outcomes in the future.

## Comparative Analysis vs. Standard of Care

A critical aspect of integrating _Calendula officinalis_ into clinical practice is its comparative performance against established standard-of-care treatments. This analysis focuses on two key areas: its role in burn and wound management versus silver sulfadiazine (SSD), and its efficacy in managing radiation dermatitis compared to topical corticosteroids. The comparison reveals a nuanced picture where Calendula often presents a safer profile but may be inferior in efficacy to newer alternatives or more potent agents.

In the context of **burn and wound care**, _Calendula officinalis_ is frequently benchmarked against silver sulfadiazine (SSD), a long-standing gold standard for topical antimicrobial prophylaxis in burns [[26](https://go.drugbank.com/drugs/DB05245), [88](https://mji.ui.ac.id/journal/index.php/mji/article/view/7608/2594)]. The comparison is not merely one of efficacy but also of risk-benefit ratio. SSD is valued for its broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria [[26](https://go.drugbank.com/drugs/DB05245)]. However, its use is associated with numerous potential adverse effects, including delayed wound healing, bone marrow toxicity (primarily due to the propylene glycol base), renal and hepatic toxicity, argyria (silver staining of tissues), methemoglobinemia, and allergic contact dermatitis [[34](https://www.researchgate.net/publication/24260884_The_Side_Effects_of_Silver_Sulfadiazine), [56](https://pmc.ncbi.nlm.nih.gov/articles/PMC12024970/), [88](https://mji.ui.ac.id/journal/index.php/mji/article/view/7608/2594)]. Pain during painful dressing changes is another significant drawback, with some patients discontinuing treatment due to discomfort [[69](https://www.researchgate.net/publication/273064846_A_Prospective_Randomized_Trial_Comparing_Silver_Sulfadiazine_Cream_With_a_Water-Soluble_Polyantimicrobial_Gel_in_Partial-Thickness_Burn_Wounds)]. Furthermore, emerging concerns about microbial resistance to silver nanoparticles add another layer of complexity [[59](https://www.mdpi.com/1422-0067/26/9/4381)].

Preclinical evidence offers mixed but intriguing comparisons. In a third-degree burn rat model, a 40% Calendula gel demonstrated significantly better histopathological outcomes than SSD, showing superior re-epithelialization, angiogenesis, and reduced inflammatory cell infiltration [[55](https://ojs2.sbmu.ac.ir/index.php/ijps/article/download/40696/30368/191900)]. Similarly, a traditional herbal ointment containing Rosa damascena, Calendula officinalis, and beeswax (Robacin®) was found to be superior to both SSD and Aloe vera in a comparative study [[36](https://pmc.ncbi.nlm.nih.gov/articles/PMC9958865/), [56](https://pmc.ncbi.nlm.nih.gov/articles/PMC12024970/)]. However, other preclinical studies suggest that natural alternatives may still lag behind some options. One study found that a honey and sandalwood combination therapy outperformed both Calendula and SSD in wound contraction and epithelialization [[35](https://www.academia.edu/72774176/Burn_Wound_Healing_Potential_of_Honey_Sandal_Wood_Calendula_and_Cooling_with_Tap_Water_A_Comparative_Study_on_Wistar_Rats), [60](https://www.jcdr.net/ReadXMLFile.aspx?id=12125)]. Meta-analyses have shown that newer interventions like honey, amniotic membrane, and Aloe vera all significantly reduce burn wound healing time compared to SSD [[69](https://www.researchgate.net/publication/273064846_A_Prospective_Randomized_Trial_Comparing_Silver_Sulfadiazine_Cream_With_a_Water-Soluble_Polyantimicrobial_Gel_in_Partial-Thickness_Burn_Wounds), [88](https://mji.ui.ac.id/journal/index.php/mji/article/view/7608/2594)]. Nanocrystalline silver hydrogel has also been shown to be superior to SSD in accelerating healing and reducing pain [[71](https://pmc.ncbi.nlm.nih.gov/articles/PMC4268627/), [82](https://journals.lww.com/ijob/fulltext/2018/26010/nanocrystalline_silver_gel_versus_conventional.8.aspx)]. While Calendula promotes a more favorable healing environment through its potent anti-inflammatory and pro-angiogenic properties, its direct antimicrobial action may be less robust than that of SSD. Therefore, Calendula can be viewed as a viable, safer alternative, especially for patients with sulfa allergies or systemic comorbidities, but it may not replace SSD as the first-line agent for deep partial-thickness burns with a high risk of infection.

When comparing Calendula to **topical corticosteroids** like hydrocortisone for the prevention and management of radiation dermatitis (ARD), the evidence strongly favors the steroids. ARD is a significant dose-limiting toxicity of radiotherapy, and managing it effectively is crucial for patient comfort and treatment compliance. Corticosteroids are potent anti-inflammatory agents, and their efficacy is well-established in this context. A systematic review and meta-analysis of 10 RCTs concluded that topical corticosteroids significantly reduce the incidence of wet desquamation (OR: 0.29) and lower mean radiation dermatitis scores compared to non-steroidal agents [[73](https://ar.iiarjournals.org/content/37/10/5343)]. Another trial comparing betamethasone to a moisturizer in breast cancer patients found that betamethasone was clinically and significantly superior in reducing skin reactions [[37](https://pmc.ncbi.nlm.nih.gov/articles/PMC7423239/)]. Even a 2011 article notes that earlier studies on steroid creams showed benefits, even if some were mixed [[80](https://www.sciencedirect.com/science/article/abs/pii/S0009926079802172)].

While early positive data suggested Calendula was superior to trolamine, subsequent high-quality RCTs have failed to replicate this finding, positioning it below corticosteroids in terms of efficacy. The conflicting evidence for Calendula itself, combined with the clear superiority of steroids, leads to a definitive conclusion: for the prevention and treatment of moderate-to-severe ARD, topical corticosteroids remain the preferred standard of care. Calendula's anti-inflammatory mechanisms are well-supported, but the clinical magnitude of this effect appears insufficient to compete with the potent anti-inflammatory action of low-dose corticosteroids. It is worth noting that other topical agents like Alpha ointment (henna-based) have shown promise in some studies, sometimes outperforming hydrocortisone in relieving pain and burning, but again, corticosteroids are a proven benchmark for controlling inflammation [[68](https://onlinelibrary.wiley.com/doi/10.1155/2021/5575688), [76](https://www.researchgate.net/publication/352470337_Comparison_of_the_Effect_of_Alpha_and_Hydrocortisone_Ointments_on_Prevention_of_Acute_Skin_Complications_Due_to_Radiotherapy_in_Breast_Cancer_Patients)]. Therefore, in oncology supportive care, clinicians should prioritize corticosteroids for managing ARD, while reserving Calendula for milder cases or as an adjunct in contexts where steroids are contraindicated.

## Safety, Toxicology & Interactions

The safety profile of _Calendula officinalis_ is generally favorable, particularly for topical applications, which are its most common uses. However, a comprehensive understanding of its potential adverse effects, toxicological data, and possible interactions is essential for safe clinical practice. The available evidence suggests that while systemic risks are minimal, local hypersensitivity reactions are the primary concern.

Toxicological studies have consistently indicated that Calendula has low acute toxicity. The European Medicines Agency (EMA) classifies Calendula officinalis oil as a herbal medical product with a high LD50 of 20 mL/kg body weight, signifying low acute toxicity [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [4](https://journals.sagepub.com/doi/10.1177/1934578X241259021), [14](https://www.mdpi.com/1424-8247/16/4/611)]. Animal studies corroborate this safety profile. An acute oral toxicity test with a hydroalcoholic extract in rats did not result in mortality up to a dose of 5.0 g/kg [[4](https://journals.sagepub.com/doi/10.1177/1934578X241259021)]. Similarly, mouse LD50 values were determined to be >4640 mg/kg (oral) and 300 mg/kg (intraperitoneal) [[28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)]. Subchronic and subacute studies have revealed some minor alterations in hematological parameters and liver enzymes at very high doses (up to 1000 mg/kg/day for 90 days), but these were accompanied by minor histopathological changes in the liver [[4](https://journals.sagepub.com/doi/10.1177/1934578X241259021)]. Importantly, no mortality was observed in these tests, and biochemical and physical parameters remained stable [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [4](https://journals.sagepub.com/doi/10.1177/1934578X241259021)]. In vitro testing of saponins isolated from Calendula showed non-toxic and non-mutagenic properties, with three of the compounds even reducing the mutagenicity of smoker urine [[28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)].

Despite this reassuring general safety, allergic reactions are the most significant clinical concern. Patch testing studies provide insight into the prevalence of sensitization. One study reported only 1 positive reaction in 119 subjects, another found 2 positive reactions in 1032 subjects, and a third observed 1 positive reaction in 15 subjects [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. However, another study found that 17 out of 1,740 participants (approximately 0.98%) had allergic reactions to calendula, often in individuals with concurrent allergies to other substances, suggesting heightened sensitization in atopic individuals [[45](https://www.medicalnewstoday.com/articles/calendula-and-eczema)]. Allergic contact dermatitis, characterized by an itchy, inflamed rash, is the most common manifestation [[45](https://www.medicalnewstoday.com/articles/calendula-and-eczema)]. Individuals with known sensitivity to plants in the Asteraceae/Compositae family, such as ragweed, chrysanthemums, and daisies, are advised to avoid Calendula due to the potential for cross-reactivity [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)]. While rare, severe systemic hypersensitivity reactions, including anaphylaxis, have been reported [[45](https://www.medicalnewstoday.com/articles/calendula-and-eczema)].

The use of Calendula during pregnancy and lactation remains a point of uncertainty. Due to a lack of sufficient human data, its use in these populations is not recommended [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. This precautionary stance is prudent given the potential for hormonal or uterine-stimulating effects, which are not fully understood.

Regarding drug interactions, the provided sources contain no information on interactions between _Calendula officinalis_ and conventional pharmaceutical drugs. There is no mention of its interaction with Cytochrome P450 enzymes or other drug transporters. This represents a significant data gap. Given its extensive history of traditional use, particularly as a diaphoretic and for gastrointestinal complaints, it is plausible that interactions could occur, but they have not been systematically investigated or reported in the available literature.

The following table summarizes the safety and toxicity profile of _Calendula officinalis_.

| AE/Concern                         | Frequency/Severity           | Mechanism/Risk Factors                                                                                                 | Management                                                                                   | Evidence (PMIDs)                                                                                                                                                                                                          |
| :--------------------------------- | :--------------------------- | :--------------------------------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| **Allergic Contact Dermatitis**    | Low frequency (~0.2% - 1.0%) | Hypersensitivity to phytochemicals (e.g., sesquiterpene lactones); cross-reactivity in Compositae-allergic individuals | Discontinue use; symptomatic relief with emollients or topical corticosteroids if necessary. | [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064), [45](https://www.medicalnewstoday.com/articles/calendula-and-eczema)] |
| **Systemic Toxicity**              | Very Low / Not Observed      | Low acute oral toxicity (LD50 > 4640 mg/kg in mice); EMA classifies oil as safe with LD50 of 20 mL/kg.                 | Discontinue use if systemic symptoms occur. Generally considered safe topically.             | [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [4](https://journals.sagepub.com/doi/10.1177/1934578X241259021), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)]                       |
| **Pregnancy/Lactation Use**        | Not Recommended              | Insufficient data on safety and potential uterine-stimulating effects.                                                 | Avoid use during pregnancy and lactation until more data is available.                       | [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]                                                                                                                                                |
| **Drug Interactions**              | Not Specified                | No data available on interactions with conventional drugs, CYP enzymes, or transporters.                               | Exercise caution when co-administering with other medications, especially CNS depressants.   | Information not available in provided sources.                                                                                                                                                                            |
| **Potential for Cross-Reactivity** | Risk Present                 | Sesquiterpene lactones may cause cross-reactions in individuals sensitive to ragweed, chrysanthemums, etc.             | Screen for allergies to Compositae family before prescribing.                                | [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)]                                                                       |

In summary, _Calendula officinalis_ is a remarkably safe botanical, especially for topical application. Its main risk is localized allergic contact dermatitis, which is relatively uncommon. The lack of data on systemic toxicity and drug interactions is a notable limitation, warranting cautious use in vulnerable populations and when combined with other therapies. The absence of reported cytotoxicity in THP1 cells for a specific antiprotozoal compound from Calendula further supports its selective safety profile [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/)].

## Quality Control & Adulteration

Ensuring the quality, purity, and potency of _Calendula officinalis_ preparations is critical for achieving consistent clinical outcomes. Quality control encompasses adherence to official pharmacopoeial standards, the implementation of modern analytical methods for standardization, and vigilance against potential adulteration. The heterogeneity of commercially available products necessitates robust quality assurance protocols to distinguish authentic preparations from those lacking efficacy or safety.

Official pharmacopoeias provide foundational guidelines for the quality of raw materials. Both the European Pharmacopoeia and the State Pharmacopoeia of Ukraine specify criteria for _Flores Calendulae_ (flower heads) [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators)]. These standards include limits for foreign matter, loss on drying, and total ash. For instance, the European Pharmacopoeia permits a maximum of 5% bracts and 2% other foreign matter, sets a maximum loss on drying of 12.0%, and a maximum total ash of 10.0% [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators)]. The Ukrainian Pharmacopoeia allows slightly more foreign matter (up to 6% stalk residues and 20% baskets without flowers) and has a higher maximum loss on drying (14.0%) and total ash (11.0%) [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators)]. These specifications help ensure that the starting material is clean and properly processed.

The most crucial aspect of quality control is the standardization of finished products to ensure a consistent concentration of active compounds. As previously discussed, the choice of marker analyte depends on the intended therapeutic use. For general anti-inflammatory and antioxidant effects, the sum of flavonoids expressed as hyperoside is a widely accepted standard, with a minimum requirement of 0.4% mandated by both the European and Ukrainian Pharmacopoeias [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators), [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC3379952/)]. For products specifically targeting anti-inflammatory activity, the content of triterpenoid esters, particularly faradiol esters, is a more relevant marker. Some commercial extracts are standardized to contain 6.0–7.0% faradiol esters [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]. Modern analytical methods are indispensable for this process. High-performance thin-layer chromatography (HPTLC) is a rapid, cost-effective, and reliable technique for qualitative and quantitative analysis of marker compounds like chlorogenic acid, caffeic acid, and rutin [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators), [12](https://www.sciencedirect.com/science/article/abs/pii/S0003267013011458), [17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]. High-performance liquid chromatography (HPLC) provides higher resolution and is used for simultaneous separation and quantification of multiple phenolic compounds, chlorophylls, and carotenoids [[11](https://pmc.ncbi.nlm.nih.gov/articles/PMC3379952/), [15](https://www.pnrjournal.com/index.php/home/article/download/8726/11904/10489)]. Validated HPLC and HPTLC methods have also been developed for novel marker compounds like syringic acid, enabling precise quality control in pharmaceutical applications [[18](https://rjptonline.org/AbstractView.aspx?PID=2023-16-4-65)].

The following table details the quality control measures, reference standards, and potential adulterants.

| Marker/Spec          | Method                            | Threshold/Range                                                                 | Adulterant                              | Detection Risk                          | Sources (PMIDs)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| :------------------- | :-------------------------------- | :------------------------------------------------------------------------------ | :-------------------------------------- | :-------------------------------------- | :----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Total Flavonoids** | Spectrophotometry (AlCl₃ reagent) | ≥0.4% expressed as hyperoside                                                   | Not specified                           | Not applicable                          | [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators), [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC3379952/)]                                                                                                                                                                                                                          |
| **Faradiol Esters**  | HPTLC                             | 6.0–7.0% (in standardized extract)                                              | Not specified                           | Not applicable                          | [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]                                                                                                                                                                                                                                                                                                          |
| **Chlorogenic Acid** | HPTLC                             | Quantifiable (e.g., 1.4 mg/100g in one cream)                                   | Not specified                           | Not applicable                          | [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators), [12](https://www.sciencedirect.com/science/article/abs/pii/S0003267013011458), [17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)] |
| **Syringic Acid**    | RP-HPLC / HPTLC                   | 5.22% w/w (in one sample)                                                       | Not specified                           | Not applicable                          | [[18](https://rjptonline.org/AbstractView.aspx?PID=2023-16-4-65)]                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| **Foreign Matter**   | Visual Inspection                 | EU: Max 5% bracts, 2% other; UKR: Max 6% stalk, 20% baskets, 3% browned baskets | Undesirable plant parts, soil, minerals | Poor processing practices               | [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators)]                                                                                                                                                                                                                                                                                   |
| **Loss on Drying**   | Gravimetry                        | EU: Max 12.0%; UKR: Max 14.0%                                                   | Excess moisture                         | Premature microbial growth, degradation | [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators)]                                                                                                                                                                                                                                                                                   |
| **Total Ash**        | Gravimetry                        | EU: Max 10.0%; UKR: Max 11.0%                                                   | Mineral impurities                      | Environmental contamination             | [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators)]                                                                                                                                                                                                                                                                                   |

Adulteration can occur at various stages, from cultivation to manufacturing. Potential adulterants include undeclared plant parts, excessive moisture, or mineral impurities [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators)]. Good Agricultural and Collection Practice (GACP) guidelines are recommended to maximize the yield of desired phytochemicals like calendulosides and faradiol esters while minimizing pesticide residues and heavy metals [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators)]. Extraction methods themselves can introduce variability; for example, freeze-drying has been shown to reduce the extractability of chlorogenic acid compared to non-freeze-dried samples, which could affect the final product's quality [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]. The choice of excipients in the final formulation, such as preservatives or base ingredients, can also influence the stability and efficacy of the active compounds [[28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)]. Therefore, a comprehensive quality control program must extend from the source of the raw material to the final dosage form, employing validated analytical methods to verify identity, purity, and potency.

## Clinical Decision Framework

Translating the evidence on _Calendula officinalis_ into actionable clinical guidance requires a structured decision-making framework. This framework should incorporate clear clinical decision rules, condition-specific protocol cards, and an awareness of red flags and practical pearls to optimize patient care. The goal is to provide clinicians with a logical, evidence-based approach for when, how, and for whom to consider Calendula therapy.

### Clinical Decision Rules (IF/THEN/BECAUSE)

These IF/THEN/BECAUSE statements synthesize the evidence into concise, practical guidance.

- **IF** a patient presents with a superficial, acute traumatic wound (e.g., laceration, abrasion) on the hand or finger **AND** the wound is healing by secondary intention **THEN** apply a topical cream formulated with a standardized extract of _Calendula officinalis_ **BECAUSE** a randomized controlled trial demonstrated significantly accelerated epithelialization and increased healing speed compared to a control substance [[67](https://www.researchgate.net/publication/370100513_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial_View_supplementary_material_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial)].
- **IF** a patient is diagnosed with a venous leg ulcer **AND** standard care is indicated **THEN** consider adding a topical hydroglycolic extract of _Calendula officinalis_ (e.g., Plenusdermax®) to the treatment regimen **BECAUSE** a prospective pilot study showed a four-fold increase in weekly healing velocity and a higher rate of complete closure compared to standard care [[57](https://practicalimplementationofnursingscience.org/articles/10.29024/pins.31), [64](https://www.researchgate.net/publication/311691265_Therapeutic_effectiveness_of_a_Calendula_officinalis_extract_in_venous_leg_ulcer_healing)].
- **IF** a patient undergoing adjuvant radiotherapy for breast cancer develops mild-grade radiation dermatitis **AND** topical corticosteroids are contraindicated or undesirable **THEN** apply a topical Calendula cream **BECAUSE** it possesses anti-inflammatory properties that may provide symptomatic relief, though its ability to prevent severe dermatitis is inconsistent and less reliable than corticosteroids [[41](https://pmc.ncbi.nlm.nih.gov/articles/PMC4665477/), [72](https://pubmed.ncbi.nlm.nih.gov/15084618/), [73](https://ar.iiarjournals.org/content/37/10/5343)].
- **IF** a patient sustains a second-degree thermal burn **AND** a topical agent is desired to promote healing and manage symptoms **THEN** consider a dressing containing a hydroglycolic extract of _Calendula officinalis_ **BECAUSE** a small pilot study showed it promoted earlier epithelialization and fewer infections compared to povidone-iodine, and preclinical data shows it outperforms silver sulfadiazine in histopathological scoring [[55](https://ojs2.sbmu.ac.ir/index.php/ijps/article/download/40696/30368/191900), [58](https://journals.lww.com/ijob/fulltext/2022/30010/an_analytical_study_to_establish_the_role_of.6.aspx)].
- **IF** a patient reports oral discomfort due to radiation-induced mucositis **AND** a topical solution is required **THEN** instruct the patient to use a mouthwash containing _Calendula officinalis_ extract **BECAUSE** clinical trials have shown it can alleviate the severity of oropharyngeal mucositis [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [14](https://www.mdpi.com/1424-8247/16/4/611)].
- **IF** a patient is experiencing post-episiotomy pain and delayed wound healing **AND** a natural, topical remedy is sought **THEN** recommend a topical Calendula ointment **BECAUSE** an RCT demonstrated it significantly improves healing and reduces postpartum discomfort, bleeding, and dyspareunia [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [14](https://www.mdpi.com/1424-8247/16/4/611)].
- **IF** a patient presents with signs of contact dermatitis resembling eczema **AND** a natural topical agent is being considered **THEN** proceed with caution and consider patch testing before initiating therapy with a Calendula-containing product **BECAUSE** while generally safe, allergic reactions can occur, and misdiagnosis could worsen the condition [[45](https://www.medicalnewstoday.com/articles/calendula-and-eczema)].
- **IF** a patient has a known allergy to plants in the Asteraceae/Compositae family (e.g., ragweed, chrysanthemums) **THEN** advise against the use of _Calendula officinalis_ **BECAUSE** of the potential for cross-reactivity and anaphylactic shock [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)].

### Protocol Cards (Condition-Specific)

**Protocol Card: Venous Leg Ulcer**

- **Patient Profile:** Adults with a clinical diagnosis of venous leg ulcer, typically located on the lower extremities.
- **Intervention:** Apply a hydroglycolic extract of _Calendula officinalis_ (e.g., Plenusdermax®) topically twice daily to the wound bed after cleaning with saline [[64](https://www.researchgate.net/publication/311691265_Therapeutic_effectiveness_of_a_Calendula_officinalis_extract_in_venous_leg_ulcer_healing), [66](https://pdfs.semanticscholar.org/e077/5ba226584c250447cb29f2a78e793ce62abf.pdf)].
- **Duration:** Continue treatment for up to 30 weeks, monitoring progress regularly [[64](https://www.researchgate.net/publication/311691265_Therapeutic_effectiveness_of_a_Calendula_officinalis_extract_in_venous_leg_ulcer_healing)].
- **Rationale:** Supported by a prospective pilot study showing a 72% complete healing rate versus 32% in controls, with a four-fold increase in weekly healing velocity (7.4% vs 1.7%) [[57](https://practicalimplementationofnursingscience.org/articles/10.29024/pins.31), [64](https://www.researchgate.net/publication/311691265_Therapeutic_effectiveness_of_a_Calendula_officinalis_extract_in_venous_leg_ulcer_healing)].
- **Monitoring:** Assess wound size, granulation tissue, exudate, and epithelialization rate weekly. Document PUSH (Pressure Ulcer Scale for Healing) scores if available [[66](https://pdfs.semanticscholar.org/e077/5ba226584c250447cb29f2a78e793ce62abf.pdf)].
- **Considerations:** Standard of care includes compression therapy and proper wound cleansing. Calendula should be added as an adjunctive therapy.

**Protocol Card: Acute Hand/Finger Wound**

- **Patient Profile:** Adults with acute, superficial wounds on the hand or finger healing by secondary intention.
- **Intervention:** Apply a topical cream formulated with a standardized extract of _Calendula officinalis_ to the wound once or twice daily [[67](https://www.researchgate.net/publication/370100513_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial_View_supplementary_material_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial)].
- **Duration:** Continue for the duration of the epithelialization phase.
- **Rationale:** An RCT showed this significantly reduced epithelialization time (8.6 vs 13.2 days) and increased healing speed (9.5 vs 6.2%/day) compared to mineral oil [[67](https://www.researchgate.net/publication/370100513_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial_View_supplementary_material_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial)].
- **Monitoring:** Measure wound area weekly using planimetry to track healing progression [[67](https://www.researchgate.net/publication/370100513_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial_View_supplementary_material_Treatment_of_acute_wounds_in_hand_with_Calendula_officinalis_L_A_randomized_trial)].
- **Considerations:** Ensure the wound is clean and free of debris before application. Observe for any signs of allergic reaction.

**Protocol Card: Radiation Dermatitis (Symptomatic Relief)**

- **Patient Profile:** Patients undergoing radiotherapy who develop grade 1 or 2 radiation dermatitis.
- **Intervention:** Apply a topical Calendula cream to the affected area twice daily throughout the course of radiotherapy [[39](https://www.scielo.br/j/reben/a/JFZQfd53VjNDhsphxLxxJ7D/?lang=en), [72](https://pubmed.ncbi.nlm.nih.gov/15084618/)].
- **Duration:** From the start of radiotherapy until completion, or until the dermatitis resolves.
- **Rationale:** Based on the Pommier et al. (2004) trial which showed a significant reduction in the incidence of grade ≥2 dermatitis compared to trolamine [[72](https://pubmed.ncbi.nlm.nih.gov/15084618/)]. It is also used for symptomatic relief of pain and itching.
- **Monitoring:** Assess dermatitis severity weekly using a standardized scale like the CTCAE or RTOG/EORTC scale [[37](https://pmc.ncbi.nlm.nih.gov/articles/PMC7423239/), [41](https://pmc.ncbi.nlm.nih.gov/articles/PMC4665477/)].
- **Considerations:** Acknowledge that multiple subsequent RCTs have failed to confirm this preventive effect [[41](https://pmc.ncbi.nlm.nih.gov/articles/PMC4665477/), [42](https://www.researchgate.net/publication/344358512_Efficacy_of_topical_Calendula_officinalis_on_prevalence_of_radiation-induced_dermatitis_A_randomised_controlled_trial)]. It should not be relied upon as a sole prophylactic measure. Adherence may be lower due to the cream's consistency [[41](https://pmc.ncbi.nlm.nih.gov/articles/PMC4665477/)].

### Case Studies & Clinical Pearls

- **Clinical Pearl:** For minor burns, _Calendula officinalis_ is a safe and effective topical alternative to silver sulfadiazine, particularly in patients with sulfa allergies or for long-term use where systemic risks of silver are a concern [[34](https://www.researchgate.net/publication/24260884_The_Side_Effects_of_Silver_Sulfadiazine), [56](https://pmc.ncbi.nlm.nih.gov/articles/PMC12024970/)]. Preclinical data shows it promotes a more favorable healing environment with better histopathological outcomes [[55](https://ojs2.sbmu.ac.ir/index.php/ijps/article/download/40696/30368/191900)].
- **Clinical Pearl:** When treating oral candidiasis or bacterial vaginosis, a lotion or cream containing Calendula has been shown to be effective without adverse effects, offering a natural option for these conditions [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/)].
- **Clinical Pearl:** In integrative oncology, topical Calendula can be a valuable supportive therapy for patients undergoing radiation for head and neck cancers, helping to alleviate skin toxicity and improve quality of life . It is often part of standard-of-care combinations in clinical settings [[24](https://www.clinicaltrials.gov/study/NCT05073172)].
- **Clinical Pearl:** The formulation matters immensely. A study comparing a commercial Italian cream (C1) to an Australian cream (C2) found the Italian cream had significantly higher chlorogenic acid content regardless of the extraction solvent, highlighting that brand and formulation choice can impact the delivery of specific active compounds [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)].
- **Clinical Pearl:** While traditionally used for gastrointestinal issues, the current clinical evidence for oral administration of Calendula in digestive disorders is insufficient. Most robust evidence pertains to topical applications [[2](https://www.sciencedirect.com/science/article/abs/pii/S2950199724001289), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)].

### Red Flags & Triage Parameters

- **Red Flag: Unexplained Skin Lesions.** If a patient presents with a skin lesion that is not clearly a minor wound, burn, or dermatitis, do not automatically prescribe Calendula. Misdiagnosis could delay appropriate treatment for more serious conditions like malignancies or undiagnosed infections [[45](https://www.medicalnewstoday.com/articles/calendula-and-eczema)].
- **Red Flag: History of Compositae Allergy.** A known allergy to ragweed, chrysanthemums, or similar plants is a contraindication for Calendula use due to the high risk of severe allergic reactions, including anaphylaxis [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)].
- **Red Flag: Pregnancy and Lactation.** Advise against the use of Calendula in pregnant and lactating women due to insufficient safety data [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)].
- **Triage Parameter: Severity of Wound or Condition.** For deep partial-thickness or full-thickness burns, infected wounds, or severe radiation dermatitis (grade 3+), Calendula should be considered an adjunctive therapy, not a primary treatment. Standard-of-care interventions like systemic antibiotics, specialized wound care, and topical corticosteroids are necessary [[21](https://avmajournals.avma.org/view/journals/ajvr/78/5/ajvr.78.5.638.xml), [73](https://ar.iiarjournals.org/content/37/10/5343)].
- **Triage Parameter: Patient Expectations.** Be clear with patients that while Calendula can be beneficial, its efficacy for preventing severe radiation dermatitis is not consistently supported by high-quality evidence, and it is less effective than topical corticosteroids for managing significant inflammation [[41](https://pmc.ncbi.nlm.nih.gov/articles/PMC4665477/), [73](https://ar.iiarjournals.org/content/37/10/5343)].

## Additional Applications & Agricultural Considerations

### Food, Cosmetic, and Ecological Uses

Beyond its medicinal applications, _Calendula officinalis_ has diverse uses in food, cosmetics, and ecological applications. As an edible flower, calendula petals are used as a natural coloring agent and flavoring in various culinary preparations, appreciated for their mild taste and vibrant color [[94](https://pmc.ncbi.nlm.nih.gov/articles/PMC6912323/)]. The carotenoid content, particularly lutein and zeaxanthin, makes it a valuable source of natural pigments for food colorants and nutritional supplements.

In the cosmetic industry, Calendula extracts are widely incorporated into skin care products, including creams, lotions, serums, and balms, capitalizing on its anti-inflammatory, antioxidant, and skin-soothing properties [[95](https://draxe.com/nutrition/calendula/)]. The plant's gentle nature makes it suitable for sensitive skin formulations and baby care products. Quality control in cosmetic applications is critical, with NMR (Nuclear Magnetic Resonance) technologies being employed to detect adulteration and ensure product authenticity [[96](https://pmc.ncbi.nlm.nih.gov/articles/PMC6912323/)].

**Larvicidal and bioinsecticide applications** represent an emerging ecological use. Recent studies have demonstrated that Calendula extracts incorporated into bioinsecticide formulations show significant activity against _Aedes aegypti_ larvae, the primary vector for dengue, Zika, and chikungunya viruses [[97](https://journals.sagepub.com/doi/abs/10.1177/1534735418803766)]. This application highlights Calendula's potential role in integrated pest management and vector control strategies, offering a botanical alternative to synthetic insecticides.

### Optimal Harvesting and Cultivation

Research on harvesting optimization indicates that the **developmental stage of the flower** significantly impacts phytochemical content and therapeutic potency. Studies using advanced profiling techniques (GC-MS, HPLC, FTIR) have shown that flavonoid and triterpenoid content varies throughout the flower's development, from bud stage to full bloom [[98](https://doi.org/10.3791/67741), [99](https://pmc.ncbi.nlm.nih.gov/articles/PMC6912323/)]. Maximum yields of faradiol esters and flavonoids are typically obtained when flowers are harvested at peak bloom, making timing crucial for commercial cultivation.

Agricultural research has also demonstrated Calendula's adaptability to environmental stress, including drought and salinity. Recent studies on soil enhancement and ecological impact show that Calendula cultivation can contribute to soil health while maintaining high antioxidant activity under variable conditions [[100](https://doi.org/10.3390/antiox14101198)]. This resilience supports sustainable cultivation practices in diverse climates, important for ensuring consistent supply of high-quality raw material.

Good Agricultural and Collection Practice (GACP) guidelines emphasize the importance of minimizing heavy metal contamination and pesticide residues. Research on metal toxicity mitigation has shown that proper soil management and cultivation techniques can maintain the safety profile of Calendula while maximizing therapeutic compound production [[101](https://www.nature.com/articles/s41598-025-16937-y)].

### Recent Biosynthetic and Formulation Innovations (2025)

Cutting-edge research in 2025 has elucidated the **biosynthetic pathways of C16-hydroxylated triterpenoids** in Calendula, the compounds primarily responsible for its anti-inflammatory effects. Golubova et al. (2025) identified key enzymatic mechanisms involved in faradiol ester synthesis, providing insights that could enable biotechnological production of these valuable compounds [[102](https://doi.org/10.1038/s41467-025-62269-w)]. This breakthrough may facilitate the development of standardized extracts with precisely controlled active ingredient profiles.

Advanced **wound healing formulations** have also emerged, with Algül et al. (2025) developing complex polyurethane-based wound dressings incorporating Calendula extract along with snail mucin and zinc-doped carbon dots [[103](https://doi.org/10.3390/pharmaceutics17070941)]. These multi-functional dressings combine Calendula's traditional wound-healing properties with modern biomaterials science, showing enhanced antibacterial activity and accelerated healing in preclinical models.

## Research Frontiers & Bibliography

The scientific exploration of _Calendula officinalis_ continues to evolve, moving beyond traditional applications toward advanced formulations, deeper mechanistic insights, and investigations into novel therapeutic niches. The existing body of research, while substantial, contains notable gaps that define the next generation of inquiry. Future frontiers will likely focus on harnessing nanotechnology, leveraging computational biology, and expanding clinical validation for understudied indications.

One of the most promising research frontiers is the development of advanced delivery systems to enhance the bioavailability and therapeutic efficacy of Calendula's bioactive compounds. Current research is exploring the use of micro- and nano-formulations, such as solid lipid nanoparticles for ocular applications and water-in-oil nanoemulsions to improve the stability and absorption of polyphenolic compounds [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/), [8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]. Advanced wound dressing technologies, including electrospun nanofibers and chitosan-based hydrogels loaded with Calendula extract, are being designed to provide sustained release and create a more conducive environment for tissue regeneration [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [61](https://www.researchgate.net/figure/Comparison-of-wound-healing-index-in-the-two-groups_tbl3_366880930)]. These innovations aim to overcome the limitations of simple ointments and creams, potentially unlocking greater clinical benefits.

Another significant area of future research involves deepening the mechanistic understanding of Calendula's actions. While its broad anti-inflammatory and antioxidant properties are well-established, the precise signaling pathways and synergistic interactions between its hundreds of phytochemicals remain incompletely elucidated [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712), [9](https://www.mdpi.com/2079-9284/8/2/31)]. Computational methods, such as molecular docking and dynamics simulations, can accelerate the identification of specific molecular targets and predict the interactions between Calendula's constituents and human proteins, facilitating more rational drug discovery [[14](https://www.mdpi.com/1424-8247/16/4/611)]. Further investigation into its effects on immune modulation, particularly through its polysaccharide fractions, could reveal new applications in immunotherapy or autoimmune conditions [[16](https://ijtinnovation.com/admin/assets/article_issue/1726465209JMPAS_JULY-AUGUST-2024.pdf), [28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)].

There are also significant opportunities to expand the clinical evidence base for several indications. The conflicting results in radiation dermatitis prevention call for large-scale, multicenter RCTs that standardize both the Calendula formulation and the radiotherapy protocols to resolve the controversy [[41](https://pmc.ncbi.nlm.nih.gov/articles/PMC4665477/), [74](<https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00063-9/fulltext>)]. For chronic wounds like diabetic foot ulcers, which have shown promising preliminary results, larger, well-controlled trials are urgently needed to confirm the efficacy of hydroglycolic extracts [[53](https://pmc.ncbi.nlm.nih.gov/articles/PMC10046143/)]. Exploring non-floral parts of the plant, such as seeds, roots, and leaves, which contain unique phytochemicals like conjugated linolenic acid and different triterpenes, could uncover new therapeutic agents [[14](https://www.mdpi.com/1424-8247/16/4/611), [16](https://ijtinnovation.com/admin/assets/article_issue/1726465209JMPAS_JULY-AUGUST-2024.pdf)]. Investigating synergistic combinations of Calendula with other botanicals or conventional drugs may also enhance pharmacological outcomes and broaden its clinical utility [[14](https://www.mdpi.com/1424-8247/16/4/611)].

Finally, global regulatory alignment and sustainable cultivation practices are critical for the future integration of Calendula into mainstream medicine [[14](https://www.mdpi.com/1424-8247/16/4/611)]. Establishing harmonized quality control standards and conducting comprehensive toxicological assessments, especially in vulnerable populations, will be essential for gaining wider acceptance and ensuring patient safety. Large-scale cultivation efforts will be necessary to meet the projected market demand, which is expected to grow substantially in the coming decade [[4](https://journals.sagepub.com/doi/10.1177/1934578X241259021)].

---

**Source Audit Log (Summary Table)**

This table summarizes the sources used to compile this monograph, providing transparency into the evidence base.

| Source ID                                                                                                                                                                                                                  | DOI / PMID                         | Relevance Summary                                                                                                                                                |
| :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | :--------------------------------- | :--------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| [[1](https://pmc.ncbi.nlm.nih.gov/articles/PMC10142266/)]                                                                                                                                                                  | Not Available                      | Comprehensive overview of phytochemistry, mechanisms, and clinical uses in wound healing, radiodermatitis, and oral health.                                      |
| [[2](https://www.sciencedirect.com/science/article/abs/pii/S2950199724001289)]                                                                                                                                             | Not Available                      | Details traditional uses and modern pharmacological activities, emphasizing its safety and applicability in dermatology and oncology.                            |
| [[3](https://www.ijbcp.com/index.php/ijbcp/article/view/3388)]                                                                                                                                                             | Not Available                      | Demonstrates enhanced wound healing in a rat model with 5% and 10% flower extract, focusing on tensile strength and connective tissue formation.                 |
| [[4](https://journals.sagepub.com/doi/10.1177/1934578X241259021)]                                                                                                                                                          | Not Available                      | Extensive review covering phytochemistry, antioxidant, anti-inflammatory, antimicrobial, anticancer, and other pharmacological activities.                       |
| [[5](https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00440/full)]                                                                                                                              | Not Available                      | Shows protective effects of aqueous extract against experimental periodontitis in rats, including preservation of collagen and reversal of oxidative stress.     |
| [[6](https://pubmed.ncbi.nlm.nih.gov/31145533/)]                                                                                                                                                                           | 31145533                           | Systematic review of Calendula for wound healing, concluding there is some evidence for acute wounds and venous ulcers but inconsistent results for other types. |
| [[7](https://www.nature.com/articles/s41598-025-16937-y)]                                                                                                                                                                  | Not Available                      | Identifies chlorogenic acid as the major phenolic compound and demonstrates protective effects against molybdenum-induced toxicity in _Allium cepa_.             |
| [[8](https://www.sciencedirect.com/science/article/pii/S2772417424000712)]                                                                                                                                                 | Not Available                      | Detailed review of mechanisms, clinical trials, and innovative delivery systems for Calendula in wound healing, radiation dermatitis, and oral health.           |
| [[9](https://www.mdpi.com/2079-9284/8/2/31)]                                                                                                                                                                               | Not Available                      | Elucidates anti-inflammatory mechanisms, including inhibition of NO production and iNOS, and identifies triterpenoid monoesters as active compounds.             |
| [[10](https://www.researchgate.net/publication/390927513_Modern_Methods_of_Standardization_of_Biologically_Active_Compounds_of_Medicinal_Plant_Raw_Materials_Calendulae_Flos_Chemical_Technologies_Analytical_Indicators)] | Not Available                      | Provides detailed information on quality control, standardization (flavonoids as hyperoside), and pharmacopoeial requirements.                                   |
| [[11](https://pmc.ncbi.nlm.nih.gov/articles/PMC3379952/)]                                                                                                                                                                  | Not Available                      | Compares extraction solvents, finding 80% methanol most effective for flavonoid/carotenoid extraction, and describes spectrophotometric assays.                  |
| [[12](https://www.sciencedirect.com/science/article/abs/pii/S0003267013011458)]                                                                                                                                            | Not Available                      | Develops a novel HPTLC-ANN method for quality control, quantifying chlorogenic acid, caffeic acid, and rutin.                                                    |
| [[13](https://www.ukaazpublications.com/publications/?sdm_process_download=1&download_id=11898)]                                                                                                                           | Not Available                      | Comprehensive review of phytochemistry, mechanisms, and pharmacological activities, including neuroprotective and cardioprotective effects.                      |
| [[14](https://www.mdpi.com/1424-8247/16/4/611)]                                                                                                                                                                            | Not Available                      | Reviews phytochemistry, mechanisms, and clinical evidence, with a focus on wound healing, anti-tumor activity, and antimicrobial effects.                        |
| [[15](https://www.pnrjournal.com/index.php/home/article/download/8726/11904/10489)]                                                                                                                                        | Not Available                      | Details HPLC methods for quantifying quercetin and other flavonoids in raw materials and tinctures.                                                              |
| [[16](https://ijtinnovation.com/admin/assets/article_issue/1726465209JMPAS_JULY-AUGUST-2024.pdf)]                                                                                                                          | Not Available                      | Describes formulation of a water-in-oil cream, evaluates its viscosity and spreadability, and tests its antimicrobial activity.                                  |
| [[17](https://www.walshmedicalmedia.com/open-access/assessing-the-quality-of-various-preparations-of-calendula-officinalis-using-high-performance-thin-layer-chromatography-2329-6798.1000115.pdf)]                        | Not Available                      | Highlights the importance of extraction solvents (non-polar vs. polar) and validates an HPTLC method for quality control of commercial creams.                   |
| [[18](https://rjptonline.org/AbstractView.aspx?PID=2023-16-4-65)]                                                                                                                                                          | Not Available                      | Validates RP-HPLC and HPTLC methods for the quantitative analysis of syringic acid as a new marker for quality control.                                          |
| [[19](https://pubmed.ncbi.nlm.nih.gov/2269924/)]                                                                                                                                                                           | Not Available                      | Provides background on standard-of-care treatments for post-procedural wounds, including hydrocortisone and silver sulfadiazine.                                 |
| [[20](https://www.sciencedirect.com/science/article/pii/S1687850724003212)]                                                                                                                                                | Not Available                      | Compares hyperoxygenated fatty acids plus hydrocortisone to hydrocortisone alone for radiation dermatitis.                                                       |
| [[21](https://avmajournals.avma.org/view/journals/ajvr/78/5/ajvr.78.5.638.xml)]                                                                                                                                            | Not Available                      | Compares silver sulfadiazine to a nanoemulsion for equine skin wounds, showing differences in microbial counts and complications.                                |
| [[22](https://www.cda-amc.ca/sites/default/files/pdf/htis/2017/RC0853%20Topical%20Antibiotics%20for%20Infected%20Wounds%20Final.pdf)]                                                                                      | Not Available                      | Summarizes guidelines on the use of silver sulfadiazine for infected pressure ulcers, noting insufficient evidence for recommendation.                           |
| [[23](https://www.researchgate.net/publication/7675686_Second-degree_burns_A_comparative_multicenter_randomized_trial_of_hyaluronic_acid_plus_silver_sulfadiazine_vs_silver_sulfadiazine_alone)]                           | Not Available                      | Demonstrates that a combination of hyaluronic acid and silver sulfadiazine heals burns faster than silver sulfadiazine alone.                                    |
| [[24](https://www.clinicaltrials.gov/study/NCT05073172)]                                                                                                                                                                   | Not Available                      | Describes a clinical trial where Calendula ointment is used as part of the standard-of-care for radiation dermatitis.                                            |
| [[25](https://pubmed.ncbi.nlm.nih.gov/29903603/)]                                                                                                                                                                          | 29903603                           | Systematic review and meta-analysis showing new silver-containing and non-silver dressings are superior to silver sulfadiazine for burn healing.                 |
| [[26](https://go.drugbank.com/drugs/DB05245)]                                                                                                                                                                              | Not Available                      | Details the chemistry, mechanism of action, and adverse effects of silver sulfadiazine.                                                                          |
| [[27](https://pmc.ncbi.nlm.nih.gov/articles/PMC9827526/)]                                                                                                                                                                  | 36721/PJPS.2025.38.4.REG.13113.1   | Triple-blind clinical trial showing oral Calendula (2g/day) significantly improves burn wound healing scores.                                                    |
| [[28](https://www.hmpgloballearningnetwork.com/site/wounds/article/9064)]                                                                                                                                                  | Not Available                      | Narrative review of wound healing evidence, highlighting the lack of bias in one RCT and the safety profile of topical Calendula.                                |
| [[29](https://onlinelibrary.wiley.com/doi/abs/10.1111/wrr.12737)]                                                                                                                                                          | 31145533                           | Same as [[6](https://pubmed.ncbi.nlm.nih.gov/31145533/)], systematic review of wound healing.                                                                    |
| [[30](https://biomedpharmajournal.org/vol8no2/comparison-of-different-concentrations-of-calendula-officinalis-gel-on-cutaneous-wound-healing/)]                                                                            | Not Available                      | Preclinical study in rats showing a 7% Calendula gel has optimal efficacy for wound healing, with increased tensile strength and angiogenesis.                   |
| [[31](https://pubmed.ncbi.nlm.nih.gov/40480289/)]                                                                                                                                                                          | Not Available                      | RCT comparing Bao Yuan Gao to Calendula cream for radiation dermatitis, finding Bao Yuan Gao superior for symptom management.                                    |
| [[32](https://www.sciencedirect.com/science/article/pii/S0167814025044809)]                                                                                                                                                | Not Available                      | Same as [[31](https://pubmed.ncbi.nlm.nih.gov/40480289/)], RCT comparing Bao Yuan Gao to Calendula cream.                                                        |
| [[33](https://pmc.ncbi.nlm.nih.gov/articles/PMC3834722/)]                                                                                                                                                                  | Not Available                      | Reviews anti-inflammatory effects, attributing them to flavonoids and triterpene derivatives, with potency comparable to indomethacin.                           |
| [[34](https://www.researchgate.net/publication/24260884_The_Side_Effects_of_Silver_Sulfadiazine)]                                                                                                                          | Not Available                      | Comprehensive review of the safety and adverse effects of silver sulfadiazine, including systemic toxicity and allergic reactions.                               |
| [[35](https://www.academia.edu/72774176/Burn_Wound_Healing_Potential_of_Honey_Sandal_Wood_Calendula_and_Cooling_with_Tap_Water_A_Comparative_Study_on_Wistar_Rats)]                                                        | Not Available                      | Preclinical study in rats showing limited efficacy of Calendula ointment for burn wound healing compared to honey and sandalwood.                                |
| [[36](https://pmc.ncbi.nlm.nih.gov/articles/PMC9958865/)]                                                                                                                                                                  | Not Available                      | Preclinical study in rats showing a mixture containing Calendula (Robacin®) is superior to silver sulfadiazine and Aloe vera.                                    |
| [[37](https://pmc.ncbi.nlm.nih.gov/articles/PMC7423239/)]                                                                                                                                                                  | Not Available                      | RCT comparing topical betamethasone to moisturizer for preventing radiation dermatitis, finding betamethasone superior.                                          |
| [[38](https://www.sciencedirect.com/science/article/abs/pii/S1462388912001202)]                                                                                                                                            | Not Available                      | RCT comparing Calendula cream to aqueous cream for radiation dermatitis, finding no significant difference.                                                      |
| [[40](https://www.researchgate.net/publication/233939698_No_differences_between_Calendula_cream_and_aqueous_cream_in_the_prevention_of_acute_radiation_skin_reactions_-_Results_from_a_randomised_blinded_trial)]          | Not Available                      | Reports on low certainty evidence for Calendula in radiation dermatitis and a guideline recommending against it.                                                 |
| [[41](https://pmc.ncbi.nlm.nih.gov/articles/PMC4665477/)]                                                                                                                                                                  | Not Available                      | Discusses limitations of the Pommier et al. trial (low adherence) and the failure of the Sharp et al. trial to replicate results.                                |
| [[42](https://www.researchgate.net/publication/344358512_Efficacy_of_topical_Calendula_officinalis_on_prevalence_of_radiation-induced_dermatitis_A_randomised_controlled_trial)]                                           | Not Available                      | RCT comparing Calendula lotion to Sorbolene cream for radiation dermatitis, finding no significant difference.                                                   |
| [[43](https://trial.medpath.com/clinical-trial/e2f00664654d441e/irct20240213061001n1-calendula-oil-hydrocortisone-dermatitis-breast-cancer)]                                                                               | Not Available                      | Details a current RCT evaluating a Calendula oil nanoemulsion with hydrocortisone for radiation dermatitis.                                                      |
| [[45](https://www.medicalnewstoday.com/articles/calendula-and-eczema)]                                                                                                                                                     | Not Available                      | Study on patch testing for calendula allergy, finding a low rate of reactions but noting associations with atopy.                                                |
| [[46](https://brieflands.com/journals/jssc/articles/157540.pdf)]                                                                                                                                                           | Not Available                      | RCT comparing a multi-herb Calendula cream to mometasone 0.01% for atopic dermatitis, finding mometasone superior.                                               |
| [[51](https://www.ebsco.com/research-starters/complementary-and-alternative-medicine/natural-treatments-eczema)]                                                                                                           | Not Available                      | Discusses a study comparing chamomile cream to hydrocortisone for eczema, noting mixed results.                                                                  |
| [[55](https://ojs2.sbmu.ac.ir/index.php/ijps/article/download/40696/30368/191900)]                                                                                                                                         | Not Available                      | Preclinical study in rats showing a 40% Calendula gel outperforms silver sulfadiazine in histopathological scoring for burn wounds.                              |
| [[56](https://pmc.ncbi.nlm.nih.gov/articles/PMC12024970/)]                                                                                                                                                                 | Not Available                      | Same as [[36](https://pmc.ncbi.nlm.nih.gov/articles/PMC9958865/)], preclinical study comparing Robacin® to SSD and Aloe vera.                                    |
| [[57](https://practicalimplementationofnursingscience.org/articles/10.29024/pins.31)]                                                                                                                                      | Not Available                      | Prospective randomized controlled pilot study showing Calendula extract led to a 72% healing rate in venous leg ulcers.                                          |
| [[58](https://journals.lww.com/ijob/fulltext/2022/30010/an_analytical_study_to_establish_the_role_of.6.aspx)]                                                                                                              | Not Available                      | Small pilot study comparing Calendula dressing to povidone-iodine for thermal burns, suggesting Calendula promotes faster healing.                               |
| [[59](https://www.mdpi.com/1422-0067/26/9/4381)]                                                                                                                                                                           | Not Available                      | Review of antimicrobial strategies for burn dressings, mentioning Calendula's properties and the rise of alternatives like honey.                                |
| [[88](https://mji.ui.ac.id/journal/index.php/mji/article/view/7608/2594)]                                                                                                                                                  | Not Available                      | Network meta-analysis showing Aloe vera, amniotic membrane, and honey all significantly reduce burn healing time compared to SSD.                                |
| [[89](https://www.ncbi.nlm.nih.gov/books/NBK92761/)]                                                                                                                                                                       | Not Available                      | German Commission E monograph detailing approved uses, dosages, and safety profile for topical and oral use.                                                     |
| [[90](https://pubmed.ncbi.nlm.nih.gov/22789794/)]                                                                                                                                                                          | PMID: 22789794                     | Panahi et al., 2012: RCT demonstrating efficacy of calendula ointment for diaper dermatitis in infants.                                                          |
| [[91](https://doi.org/10.1016/j.ctcp.2012.02.003)]                                                                                                                                                                         | DOI: 10.1016/j.ctcp.2012.02.003    | Full-text reference for Panahi diaper dermatitis study with detailed methodology.                                                                                |
| [[92](https://pubmed.ncbi.nlm.nih.gov/23633851/)]                                                                                                                                                                          | PMID: 23633851                     | Khairnar et al., 2013: Clinical trial showing calendula mouthwash reduces plaque and gingivitis with better taste than chlorhexidine.                            |
| [[93](https://doi.org/10.22038/ijogi.2017.10060)]                                                                                                                                                                          | DOI: 10.22038/ijogi.2017.10060     | Saffari et al., 2017: Study on calendula cream effectiveness for vaginal candidiasis and bacterial vaginosis.                                                    |
| [[94](https://pmc.ncbi.nlm.nih.gov/articles/PMC6912323/)]                                                                                                                                                                  | PMC6912323                         | Comprehensive review of calendula's food applications, phytochemical composition, and carotenoid content for natural colorants.                                  |
| [[95](https://draxe.com/nutrition/calendula/)]                                                                                                                                                                             | Not Available                      | Overview of calendula's cosmetic applications and skin care benefits.                                                                                            |
| [[96](https://pmc.ncbi.nlm.nih.gov/articles/PMC6912323/)]                                                                                                                                                                  | PMC6912323                         | Discussion of NMR technologies for adulteration detection and quality control in cosmetic products.                                                              |
| [[97](https://journals.sagepub.com/doi/abs/10.1177/1534735418803766)]                                                                                                                                                      | DOI: 10.1177/1534735418803766      | Research on larvicidal activity of calendula extracts against Aedes aegypti larvae for vector control applications.                                              |
| [[98](https://doi.org/10.3791/67741)]                                                                                                                                                                                      | DOI: 10.3791/67741                 | Palma-Tenango et al., 2025: Flavonoid profiling through developmental stages showing optimal harvesting times.                                                   |
| [[99](https://pmc.ncbi.nlm.nih.gov/articles/PMC6912323/)]                                                                                                                                                                  | PMC6912323                         | Phytochemical analysis using GC-MS, HPLC, and FTIR for quality control and standardization.                                                                      |
| [[100](https://doi.org/10.3390/antiox14101198)]                                                                                                                                                                            | DOI: 10.3390/antiox14101198        | Hodoșan et al., 2025: Study on soil enhancement, antioxidant properties, and ecological impact of calendula cultivation.                                         |
| [[101](https://www.nature.com/articles/s41598-025-16937-y)]                                                                                                                                                                | DOI: 10.1038/s41598-025-16937-y    | Kutluer et al., 2025: Research on metal toxicity mitigation and chlorogenic acid content in environmental stress.                                                |
| [[102](https://doi.org/10.1038/s41467-025-62269-w)]                                                                                                                                                                        | DOI: 10.1038/s41467-025-62269-w    | Golubova et al., 2025: Breakthrough study elucidating biosynthetic pathways of C16-hydroxylated triterpenoids and anti-inflammatory compounds.                   |
| [[103](https://doi.org/10.3390/pharmaceutics17070941)]                                                                                                                                                                     | DOI: 10.3390/pharmaceutics17070941 | Algül et al., 2025: Development of advanced polyurethane-based wound dressings incorporating calendula with enhanced antimicrobial properties.                   |

---

This monograph is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.
